Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3863 Target Snapshot

Serine/threonine-protein kinase D1 · SINGLE PROTEIN · Homo sapiens

1,250Compounds
356Assays
6Approved Drugs
390.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q15139. Use UniProt Q15139 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q15139 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Serine/threonine-protein kinase D1 as ChEMBL target CHEMBL3863, mapped to UniProt Q15139. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Serine/threonine-protein kinase D1
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL3863
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q15139
Serine/threonine-protein kinase D1
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Serine/threonine-protein kinase D1 is the right protein anchor across sources, using UniProt Q15139 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelSerine/threonine-protein kinase D1
UniProt AccessionQ15139
Component TypeProtein
Sequence Length912 aa

Serine/threonine-protein kinase D1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Serine/threonine-protein kinase D1, mapped to UniProt Q15139. Sequence length is 912 aa.

Mapped IDQ15139
Review nameSerine/threonine-protein kinase D1
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

6
Approved
2
Phase III
3
Phase II
7
Phase I
Assay Mix

Activity Type Distribution

IC50213.0
KI20.0
EC5032.0
KD125.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1215711 9.4 IC50 0.4 Preclinical
CHEMBL1214998 9.22 IC50 0.6 Preclinical
CHEMBL4113471 9.05 Ki 0.9 Preclinical
CHEMBL1214711 9.0 IC50 1.0 Preclinical
CHEMBL1214712 9.0 IC50 1.0 Preclinical
CHEMBL1214860 9.0 IC50 1.0 Preclinical
CHEMBL1214999 9.0 IC50 1.0 Preclinical
CHEMBL1215000 9.0 IC50 1.0 Preclinical
CHEMBL1215001 9.0 IC50 1.0 Preclinical
CHEMBL1215002 9.0 IC50 1.0 Preclinical
Distribution

pChEMBL Value Distribution

14
5.0
28
5.5
48
6.0
35
6.5
40
7.0
31
7.5
21
8.0
12
8.5
19
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

BRIGATINIB
CHEMBL3545311
Approved 2017
NERATINIB
CHEMBL180022
Approved 2017
NINTEDANIB
CHEMBL502835
Approved 2014
CRIZOTINIB
CHEMBL601719
Approved 2011
SUNITINIB
CHEMBL535
Approved 2006
Assay Landscape

Assay Landscape

356
Total Assays
186
Tested Compounds
1
Assay Types
Binding — 356 assays, 186 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 284 150 7.1
assay format 38 10 8.0
cell-based format 28 26 6.0
subcellular format 6 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine